Skip to content
Andarix
  • Home
  • About
  • Products
    • Tozaride ®
    • Companion Diagnostics
    • Our Science
  • News & Events
  • Contact
Andarix
  • Home
  • About
  • Products
    • Tozaride ®
    • Companion Diagnostics
    • Our Science
  • News & Events
  • Contact

Archive for December 2022

Andarix Pharmaceuticals to Present at Clinical Trials in Rare Diseases Conference 2022

December 7, 2022 | 0

Personalized and targeted medicine for rare lung and other cancers SOMERVILLE, MA —December 6, 2022— ANDARIX Pharmaceuticals, a leader in the discovery and development of targeted peptide therapy for cancer announced today that it will present its clinical strategy and results at the upcoming clinical trials in rare diseases conference. The Clinical Trials in Rare…

Read More

Recent Posts

  • Andarix Pharmaceuticals to Present at Clinical Trials in Rare Diseases Conference 2022
  • Andarix Pharmaceuticals to Present Targeted Lung Cancer Technology at Clinical Conference
  • Andarix Pharmaceuticals to Present Lung Cancer Therapy Technology at Clinical Trials Conference
  • Andarix Pharmaceuticals Awarded Trademark for Tozaride by the US Patent and Trademark Office
  • Andarix Pharmaceuticals to Present at Neosynth Breast Cancer Conference

Recent Comments

    Archives

    • December 2022
    • October 2022
    • April 2019
    • October 2018
    • July 2018
    • February 2018
    • October 2017
    • September 2017
    • October 2015
    • September 2015
    • April 2015
    • December 2014
    • September 2014
    • July 2014
    • February 2014

    Categories

    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • Home
    • About Us
    • Products
    • News & Events
    • Contact Us